Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Purple Biotech Ltd. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +4 vs. Q3 2022
- Shares held
- 173.6K
- +62.9K (+56.8%) vs. Q3 2022
- Total value
- $238.6K
- +$14.6K (+6.5%) vs. Q3 2022
- New holders
- 6
- 2 more added
- Sold out
- 2
- 2 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $141.0K |
| Q1 2026 | 15 | $305.6K |
| Q4 2025 | 19 | $513.2K |
| Q3 2025 | 16 | $75.9K |
| Q2 2025 | 14 | $133.7K |
| Q1 2025 | 9 | $134.3K |
| Q4 2024 | 14 | $377.9K |
| Q3 2024 | 11 | $946.1K |
| Q2 2024 | 21 | $775.9K |
| Q1 2024 | 21 | $1.77M |
| Q4 2023 | 20 | $1.90M |
| Q3 2023 | 18 | $275.9K |
| Q2 2023 | 17 | $388.3K |
| Q1 2023 | 16 | $224.2K |
| Q4 2022 | 15 | $238.6K |
| Q3 2022 | 11 | $224.0K |
| Q2 2022 | 14 | $310.2K |
| Q1 2022 | 14 | $1.77M |
| Q4 2021 | 13 | $4.09M |
| Q3 2021 | 12 | $5.27M |
| Q2 2021 | 13 | $3.72M |
| Q1 2021 | 15 | $2.40M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 45,865 | $63.3K | 0.00% | +45,865 | New |
| Fisher Asset Management, LLC | 32,200 | $44.0K | 0.00% | +32,200 | New |
| Morgan Stanley | 21,870 | $30.2K | 0.00% | +5,600+34.4% | Added |
| Ground Swell Capital, LLC | 14,719 | $20.3K | 0.09% | +14,719 | New |
| Venture Visionary Partners LLC | 13,068 | $18.0K | 0.00% | 00.0% | Unchanged |
| Wealth Advisors of Iowa, LLC | 12,505 | $17.3K | 0.01% | +1,200+10.6% | Added |
| Geode Capital Management, LLC | 12,666 | $17.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 8,289 | $11.4K | 0.00% | −2,239−21.3% | Reduced |
| Group One Trading, L.P. | 4,201 | $5.80K | 0.00% | −19,936−82.6% | Reduced |
| Fiduciary Alliance LLC | 3,250 | $4.49K | 0.00% | +3,250 | New |
| Belpointe Asset Management LLC | 2,600 | $3.59K | 0.00% | +2,600 | New |
| Advisory Services Network, LLC | 1,995 | $2.75K | 0.00% | +1,995 | New |
| North Star Investment Management Corp. | 300 | $414 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 108 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 10 | – | – | 00.0% | Unchanged |
| Washington Trust Bank | 0 | $0 | 0.00% | −16,454−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,918−100.0% | Sold out |